C12N 7/04
Inactivation or attenuation
Official title: Inactivation or attenuation; Producing viral sub-units
C12N7/04 (Inactivation or attenuation) appears on 209 US grants and 286 published applications in this corpus.
Search patents in C12N- Granted patents
- 209
- Published applications
- 286
- Assignees
- 223
- Inventors
- 634
- Latest grant
- 4 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1992 | 1 | 0 |
| 1993 | 0 | 0 |
| 1994 | 3 | 0 |
| 1995 | 2 | 0 |
| 1996 | 4 | 0 |
| 1997 | 4 | 0 |
| 1998 | 2 | 0 |
| 1999 | 3 | 0 |
| 2000 | 6 | 0 |
| 2001 | 4 | 0 |
| 2002 | 5 | 3 |
| 2003 | 2 | 2 |
| 2004 | 2 | 1 |
| 2005 | 0 | 3 |
| 2006 | 0 | 2 |
| 2007 | 1 | 3 |
| 2008 | 0 | 1 |
| 2009 | 2 | 4 |
| 2010 | 1 | 5 |
| 2011 | 2 | 3 |
| 2012 | 5 | 6 |
| 2013 | 2 | 9 |
| 2014 | 5 | 10 |
| 2015 | 7 | 11 |
| 2016 | 7 | 18 |
| 2017 | 11 | 18 |
| 2018 | 7 | 42 |
| 2019 | 25 | 24 |
| 2020 | 25 | 22 |
| 2021 | 16 | 22 |
| 2022 | 20 | 15 |
| 2023 | 8 | 17 |
| 2024 | 14 | 16 |
| 2025 | 11 | 10 |
| 2026 | 2 | 19 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Attenuated virus of flavivirus virus and use thereof4 Aug 2026US 12,697,380 B2Zhejiang Free Trade Zone Hongan Base Biotechnology Co., Ltd.
- Canine parvovirus23 Jun 2026US 12,661,395 B2Intervet Inc.
- Method for constructing gE protein-deleted pseudorabies virus strain using adenine base editor and use thereof12 Aug 2025US 12,385,015 B2Jiangxi Agricultural University
- Recombinant bovine immunodeficiency virus-like particles comprising an influenza HA transmembrane domain and C-terminus20 May 2025US 12,303,560 B2Medigen, Inc.
- Recombinant adenoviruses carrying transgenes22 Apr 2025US 12,280,123 B2EpicentRx, Inc.
- Canine parvovirus10 Sep 2026US 2026/0263590 A1Intervet Inc.
- Use of prime editing in correcting mutations in cdkl520 Aug 2026US 2026/0242800 A1President and Fellows of Harvard College
- Composition including virus like particles (vlps), a kit, and method for antitumoral therapy13 Aug 2026US 2026/0234573 A1Cnpem- Centro Nacional De Pesquisa Em Energia E Materiais
- Improvements in and relating to measurement of solutions30 Jul 2026US 2026/0219218 A1University of Limerick
- Rna-guided endonuclease system and use thereof in gene editing23 Jul 2026US 2026/0209761 A1Harbin Institute of Technology
Most cited
By later US patents
- Photodynamic inactivation of viruses in blood cell-containing compositions94US 5,120,649 ANew York Blood Center, Inc. · 1992
- Process for the sterilization of biological compositions and the product produced thereby64US 6,087,141 ANew York Blood Center, Inc. · 2000
- Method for inactivating pathogens in red cell compositions using quinacrine mustard63US 5,691,132 ACerus Corporation · 1997
- Systems and methods for eradicating contaminants using photoactive materials in fluids like blood61US 5,300,019 ABaxter International Inc. · 1994
- Treating red blood cell solutions with anti-viral agents57US 5,559,250 ASteritech, Inc. · 1996